Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (231-240 of 459) with videos related to

Pageof 46
Sort By:
International Journal of Molecular Sciences|July 2, 2021
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?Andrea Marchetti, Matteo Rosellini, Veronica Mollica, et al.
Expert Review of Molecular Diagnostics|September 10, 2019
Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsiesAlessia Cimadamore, Francesco Massari, Matteo Santoni, et al.
Molecular and Clinical Oncology|July 7, 2018
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibitionCarlo Capalbo, Francesca Belardinilli, Marco Filetti, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2013
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinomaMatteo Santoni, Francesco Massari, Consuelo Amantini, et al.
Translational Andrology and Urology|April 14, 2021
Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?Veronica Mollica, Alessandro Rizzo, Vincenzo Di Nunno, et al.
Cancer Treatment Reviews|February 7, 2018
Immune checkpoint inhibitors for metastatic bladder cancerFrancesco Massari, Vincenzo Di Nunno, Marta Cubelli, et al.
Cancer Treatment Reviews|June 11, 2018
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversiesFrancesco Massari, Matteo Santoni, Vincenzo di Nunno, et al.
Drugs in Context|June 15, 2018
Immunotherapy in renal cell carcinoma: latest evidence and clinical implicationsMatteo Santoni, Francesco Massari, Vincenzo Di Nunno, et al.
Current Drug Targets|February 23, 2016
Emerging Immunotargets and Immunotherapies in Prostate CancerRodolfo Montironi, Matteo Santoni, Valeria Sotte, et al.
Molecular Diagnosis & Therapy|October 24, 2023
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?Nicole Conci, Elisa Tassinari, Valentina Tateo, et al.
Pageof 46

Showing results (231-240 of 459) with videos related to

Sort By:
Pageof 46
International Journal of Molecular Sciences|July 2, 2021
The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?Andrea Marchetti, Matteo Rosellini, Veronica Mollica, et al.
Expert Review of Molecular Diagnostics|September 10, 2019
Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsiesAlessia Cimadamore, Francesco Massari, Matteo Santoni, et al.
Molecular and Clinical Oncology|July 7, 2018
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibitionCarlo Capalbo, Francesca Belardinilli, Marco Filetti, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2013
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinomaMatteo Santoni, Francesco Massari, Consuelo Amantini, et al.
Translational Andrology and Urology|April 14, 2021
Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?Veronica Mollica, Alessandro Rizzo, Vincenzo Di Nunno, et al.
Cancer Treatment Reviews|February 7, 2018
Immune checkpoint inhibitors for metastatic bladder cancerFrancesco Massari, Vincenzo Di Nunno, Marta Cubelli, et al.
Cancer Treatment Reviews|June 11, 2018
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversiesFrancesco Massari, Matteo Santoni, Vincenzo di Nunno, et al.
Drugs in Context|June 15, 2018
Immunotherapy in renal cell carcinoma: latest evidence and clinical implicationsMatteo Santoni, Francesco Massari, Vincenzo Di Nunno, et al.
Current Drug Targets|February 23, 2016
Emerging Immunotargets and Immunotherapies in Prostate CancerRodolfo Montironi, Matteo Santoni, Valeria Sotte, et al.
Molecular Diagnosis & Therapy|October 24, 2023
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?Nicole Conci, Elisa Tassinari, Valentina Tateo, et al.
Pageof 46